30 April 2020
Introduction
With the backdrop of COVID-19 spreading around the world, we believe that funds will flow into biotech companies, making biotech IPO in Hong Kong very attractive to founders, investors and other stakeholders in this stock market. In this guidebook, we focus on topics in relation to listing biotech companies in the Hong Kong stock market.
The following topics are discussed:
-
Snapshot of biotech companies already listed in Hong Kong by March 2020
-
Listing requirements of biotech companies
-
Preparatory steps for an IPO
-
Typical timeline of a Hong Kong IPO
-
Benefits of a listed company
Please click here to access the full guide.
If you have any questions about the topics in this guidebook, please contact one of the contacts on the right, or alternatively your usual contact in the team.
For further information, please contact:
Kurt Lau, Partner, Hill Dickinson Hong Kong
